Lilly expands pain pipeline via US$ 1 bn SiteOne buyout; US cancels funding for Moderna’s bird flu vaccine
In news this week, Eli Lilly has placed a billion-dollar bet on non-opioid pain management by acquiring SiteOne Therapeutics fo...
Impressions : 799
Trump signs ‘most favored nation’ executive order to slash drug costs; Sanofi, Takeda pledge mega investments in US
The US President Donald Trump’s dramatic intervention in pharmaceutical pricing took centerstage as the White House unvei...
Impressions : 1023
FDA panel votes against Intercept’s liver med Ocaliva; Lilly’s Ebglyss wins approval for eczema
Intercept Pharmaceuticals
faced a major setback as a US Food and Drug Administration (FDA) panel voted
against the confirmato...
Impressions : 1205
GSK’s COPD, long-acting asthma drugs score late-stage wins; Novo’s weight-loss drug Saxenda found to be safe in kids
GSK scored a significant late-stage win with its asthma drug Nucala in treating chronic obstructive pulmonary disease (COPD). I...
Impressions : 1177
Sun, Dr. Reddy’s rework strategies to deal with US market; Novartis sells troubled US biz to Aurobindo
This week, Phispers has news on Indian generic drug makers. First, Sun Pharma and Dr. Reddy’s Laboratories announced thei...
Impressions : 2942
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.